CHICAGO--(BUSINESS WIRE)--Sirtex, a leading developer of targeted and innovative cancer therapies, will be featured on an upcoming episode of “The Economic Report” as part of the show’s Medical Innovations for the 21st Century series titled, Leading Developments in Liver Cancer Technologies. The segment focuses on the challenges of treating metastatic liver tumors and the role of SIR-Spheres microspheres in providing patients with a treatment option. The episode will air locally on CNN Headline News/Comcast Cable on Saturday, May 23 at 8:24 a.m. and 10:24 a.m. Sirtex manufactures SIR-Spheres microspheres, the only FDA-approved microsphere therapy for colorectal liver metastases.
